Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Numinus Wellness Inc. (V:NUMI)

Business Focus: Biotechnology & Medical Research

Get the company report for the most recent outlook updated daily

Insider Chart - Past 6 Months

INK Ultra Money Free

Insider Filings

Latest 10 SEDI filings for NUMI within the last 6 months
Loading...
See all filings within the past 6 months

Company News

Oct 22, 2020 08:00 ET
Numinus First Canadian Public Company to Complete Legal Harvest of Psilocybe Mushrooms
Numinus Bioscience's developments include harvesting its first flush of Psilocybe mushrooms at its Health Canada licensed facility.
Read full article
Oct 14, 2020 08:30 ET
Numinus Appoints Multidisciplinary Global Leaders to its General Advisory Council
Advisors, including human performance expert Jamie Wheal and mental health advocate Ben Nemtin, join Numinus to help guide and inform company leadership  ...
Read full article
See more news stories

Valuation Ratios

Industry
Sector
Beta
N/A
--
--
Price to Sales - TTM
--
18.02
10.78
Price to Book - most recent quarter
3.57
4.04
2.96
Price to Cash Flow per share - TTM
--
13.49
11.70
Price to Free Cash Flow per share - TTM
--
48.44
20.59
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Oct 15, 2020295,443-151,009
Sep 30, 2020446,452153,867
Sep 15, 2020292,585-175,788
See Short Report

Business Summary

Sector:  Healthcare Industry:  Biotechnology & Medical Research

Numinus Wellness Inc. (Numinus) is a Canada-based health care company focused on creating an ecosystem of wellness solutions through access, research, training and therapies centered on psychedelic therapies. The Company, through its subsidiary Salvation Botanicals Ltd, has a Health Canada cannabis testing license and dealer's license. The testing license allows the Company to test and analyze cannabis products from licensed producers, and the dealer's license allows the Company to test, possess, buy and sell methylenedioxymethamphetamine (MDMA), psilocybin, psilocin, dimethyltryptamine (DMT) and mescaline. Numinus also operates a stand-alone center offering patients integrative health solutions.

See business summary

 

Twitter

Search (past week) for $NUMI.CA NUMI.V